Scope Pseudomonas aeruginosa, a ubiquitous opportunistic pathogen considered one of
the paradigms of antimicrobial resistance, is among the main causes of hospital-acquired …

Background As increasing antibiotic resistance in Acinetobacter baumannii poses a global
healthcare challenge, understanding its evolution is crucial for effective control strategies …

Ceftazidime-avibactam (CZA) resistance is a huge threat in the clinic; however, the
underlying mechanism responsible for high-level CZA resistance in Pseudomonas …

Pseudomonas aeruginosa is a notorious multidrug‐resistant pathogen that poses a serious
and growing threat to the worldwide public health. The expression of resistance …

Abstract Background The landscape of Pseudomonas infective endocarditis (IE) is evolving
with the widespread use of cardiac implantable devices and hospital-acquired infections …

The antibiotics we rely on to treat bacterial infections are becoming increasingly ineffective
as antibiotic resistance spreads around the globe. 1 Certain bacterial pathogens, such as …

The incidence of Pseudomonas aeruginosa infections in healthcare environments,
particularly in low-and middle-income countries, is on the rise. The purpose of this study was …

Background Pseudomonas aeruginosa is a major cause of hospital-acquired and chronic
infections, characterised by an extraordinary capacity to develop antimicrobial resistance …

The emergence and spread of antibiotic resistance in bacterial pathogens is a global health
threat. One important unanswered question is how antibiotic resistance influences the ability …

The use of immune compounds as antimicrobial adjuvants is a classic idea recovering
timeliness in the current antibiotic resistance scenario. However, the activity of certain …